Founded in 2023 and backed by ATEM Capital, PGxAI operates an AI-powered pharmacogenetics platform focused on precision medicine. The company combines proprietary algorithms and…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see PGxAI →Already a subscriber? Sign in
Xcout Intel tracks PGxAI continuously — this profile deepens as new filings, funding, people and hiring data arrive.